Targeted therapy treats mixed histiocytosis following multiple skull relapses

Post author:admin
Post published:April 13, 2026
Post category:uncategorized

Mixed histiocytosis (Langerhans cell histiocytosis [LCH] / Erdheim-Chester disease [ECD]) developing after treatment for initial skull LCH is not well recognized.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Study reveals a rare genotype with significant impact on women’s health

Stopping metformin early linked to higher dementia risk in older adults with type 2 diabetes

Surgery first strategy could lead to better weight loss outcomes

Helpful Links

Subscribe To Us